Related Experiment Video
Updated: May 6, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
Concomitant patch test reactions to mercapto mix and mercaptobenzothiazole: retrospective analysis from the North
Erin M Warshaw1, Srihari I Raju, C G Toby Mathias
1From the *Department of Dermatology, Veterans Affairs Medical Center, University of Minnesota, Minneapolis, MN; †Department of Dermatology, University of Cincinnati, Cincinnati, OH; ‡Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; §Department of Dermatology, Columbia University, New York, NY; ∥Department of Dermatology, University of California San Francisco, San Francisco, CA; ¶Department of Dermatology, Cleveland Clinic, Cleveland, OH; #Division of Dermatology, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada; **Dartmouth-Hitchcock Medical Center, Lebanon, NH; ††Ohio State University Medical Center, Columbus, OH; ‡‡Department of Dermatology, University of Louisville, Louisville, KY; §§Department of Dermatology, Pennsylvania State University, Philadelphia, PA; ∥∥Division of Dermatology, University of Ottawa, Ottawa, Ontario, Canada; and ¶¶Department of Dermatology, Oregon Health Science University, Portland, OR.
Background:
Mercaptobenzothiazole (MBT) and mercapto compounds are primarily used in rubber products.
Objective:
This study aimed to examine concomitant-positive rates of MBT (1% pet) and the 4-part mercapto mix (MM) (1% pet).
Design:
This is a retrospective cross-sectional data from the North American Contact Dermatitis Group.
Results:
A total of 30,880 patients were patch tested to MM and MBT. There were 333 positive reactions to MM and 427 positive reactions to MBT. Ninety-eight patients were positive to MM alone, 192 to MBT alone, and 235 reacted to both. Forty-five percent (192/427) of MBT reactions would have been missed by only testing to MM, and 29% (98/333) of MM reactions would have been missed by testing to MBT alone. Most of these "missed" reactions, however, were doubtful (+/-) or mild (+) (MBT, 65%; MM, 78%), whereas most reactions in patients who reacted to both were moderate (++) and/or strong (+++) (52.3%). Gloves were the most common source.
Conclusions:
Mercaptobenzothiazole is the preferential screening allergen for mercapto compounds because of the following: (1) greater proportion of missed reactions with MM; (2) greater proportion of doubtful/mild reactions in the missed group for MM; and (3) in the group positive to both, the low rate (2%) of moderate/strong reactions to MM and doubtful/mild reactions to MBT as compared with the converse (21%). Mercapto mix may be useful in an auxiliary rubber series.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Allergic Drug Reactions
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Hypersensitivity Reactions: Immune-Complex Reactions
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...

